Smokeless tobacco is used far less than cigarettes, primarily among men and young people, but it has become a cause for concern due to links with adverse health effects and identification as a cause of cancer.
Survey results and biomarkers published in Cancer Epidemiology, Biomarkers&Prevention, a journal of the American Association for Cancer Research, find that U.S. adults who used only smokeless tobacco products had higher levels of biomarkers of exposure to nicotine and a cancer-causing toxicant -- the tobacco-specific nitrosamine NNK -- compared with those who only used cigarettes.
Brian Rostron, PhD, an epidemiologist in the Center for Tobacco Products at the U.S. Food and Drug Administration (FDA)